Belgium ∙ 'Sunshine' in Belgium: New Statutory Transparency Requirements for Life Sciences Companies journal article Eveline Van Keymeulen, Tine Carmeliet European Pharmaceutical Law Review, Volume 1 (2017), Issue 1, Page 26 - 30
Are You AI’S Favourite? EU Legal Implications of Biased AI Systems in Clinical Genetics and Genomics Anastasiya Kiseleva, Paul Quinn
A Case of Unforeseen Adverse Side-Effects? The Ireland/Northern Ireland Protocol and Medicines Regulation George Peretz, Xisca Borrás